Gap Selling vs. MEDD(P)ICC: A Complete Comparison for Sales Teams

The question sales teams running MEDD(P)ICC rarely get a clear answer to is how their reps should run discovery. MEDD(P)ICC was built in the early 1990s by Jack Napoli and Dick Dunkel at PTC to identify whether a deal had the characteristics of a winner. A Sales Growth Company describes the framework’s scope directly: “This framework does not contain skills training in terms of what information to gain or how to gain it. It is only a deal management structure intended to connect to a sales methodology.” That is a significant structural gap when the central problem for most B2B sales teams is that reps cannot run discovery deep enough to create the conditions MEDD(P)ICC is designed to track.

Gap Selling is a complete selling methodology with integrated deal management. The diagnostic framework drives both what reps learn to find in a buyer’s business and how that information is recorded across the sales cycle. Where MEDD(P)ICC requires a methodology to connect to, Gap Selling brings the methodology with it.

What MEDD(P)ICC Is and What It Isn’t

MEDD(P)ICC has 8 fields organized in three categories. The Value fields cover Metrics and Implicate Pain. The Stakeholder fields cover Economic Buyer, Champion, and Competition. The Process fields cover Decision Criteria, Decision Process, and Paper Process.

The framework is open-source. There is no certifying authority, no single licensed version, and no canonical training curriculum. The primary providers, including MEDDICC, MEDDPICC, Force Management, MyDealCoaching, MEDDPICC Sales, and MEDDIC Sales Methodology, each interpret the same fields differently. The Implicate Pain field is the clearest example. Some providers treat it as confirming the buyer understands the consequences of inaction. Others treat it as making the buyer personally feel the emotional weight of the problem. Gap Selling explicitly rejects the latter. Good selling does not require manufacturing emotional pressure in a buyer to move a deal forward.

The absence of a certifying authority creates a standardization problem. When a new hire joins a team running MEDD(P)ICC, the definition they learn of “Implicate Pain” or “Decision Criteria” depends on which provider trained their manager and how much of that training survived internal translation. The field names are consistent across providers. What belongs in those fields is not.

The Structural Problem: A Checklist Cannot Teach Discovery

Checking the Implicate Pain box means a rep discussed pain with a buyer. The check confirms the conversation occurred. It cannot confirm whether the rep diagnosed the full depth of the buyer’s current situation, identified the root cause of the business problem, calculated the cost of inaction, or understood the emotional stake the buyer has in solving it. The field records that discovery was attempted. It cannot verify that it went deep enough to matter.

Gap Selling’s Problem Identification Chart (the PIC) defines what a complete answer looks like for each diagnostic field. Reps and managers can inspect whether a field is genuinely populated or just populated with a placeholder. MEDD(P)ICC has no equivalent standard for diagnostic completeness. A field can be checked with a single surface-level pain statement, and there is no internal measure in the framework that distinguishes that from a fully diagnosed problem.

The commercial consequence is that MEDD(P)ICC-managed deals can look qualified while the underlying diagnosis is shallow. A fully populated MEDD(P)ICC scorecard does not confirm that the rep understands the buyer’s business problem, its root cause, or why solving it is worth a decision now. Those are the conditions that move a deal. The scorecard tracks their presence without verifying their depth.

Problem vs. Pain: The Core Diagnostic Conflict

MEDD(P)ICC’s Implicate Pain field traces to the Sandler Pain Funnel, developed in the 1960s. Pain, in this context, bundles the buyer’s emotion, business problem, technical issues, and business impacts under one umbrella concept. A rep who checks this field has confirmed that some version of pain exists. What they have not confirmed is which element drives the buying decision or what specifically is broken inside the buyer’s business that the seller’s product addresses.

Gap Selling separates these into four distinct required fields: Business Problem, Impact, Emotion, and Root Cause. Root Cause is absent from MEDD(P)ICC’s entire 8-field structure. A rep who cannot connect the buyer’s technical root cause to the product’s mechanism of action builds the case for purchase on business outcomes and emotional stakes alone. When the conversation reaches a competing product with similar outcomes, differentiation collapses to features and price. Root Cause is the link between the buyer’s business problem and the specific product addressing it. MEDD(P)ICC never requires it.

Teams that move from pain-based discovery to problem-centric diagnosis report outcomes that reflect more than incremental improvement. Emburse deployed Gap Selling’s Problem-Centric Operating System across seven sales teams and over 100 reps and reported 23% higher win rates, 140% more bookings, and 70% larger deal sizes. Matt Gahr, CRO at Emburse, attributed those results to where reps now start: inside the buyer’s business problem before any solution conversation begins.

Cart.com reported 300% larger average deal sizes and 20% higher win rates, reaching those results within 90 days of training. Televerde’s EVP of Global Sales, Alicia Rasta, described win rates improving from 11% to 24% and the average sales cycle dropping from 18 months to 89 days. Before choosing Gap Selling, Televerde had evaluated Sandler, SPIN Selling, Challenger Sale, and Miller Heiman.

Deal Management: 14 Fields vs. 8

Gap Selling has 14 fields. Eleven of those address the diagnostic environment: five covering the buyer’s current state (Physical/Literal Situation, Business Problems, Impacts, Emotions, Root Cause), the Gap itself, and five mirrored future state fields. The remaining three fields cover Decision Criteria, Buying Process, and Next Yes.

MEDD(P)ICC has 8 fields. Six of those cover stakeholder identification and sales cycle management: Champion, Economic Buyer, Competition, Decision Criteria, Decision Process, and Paper Process. All six map to sub-categories inside a single Gap Selling field: Buying Process. The two MEDD(P)ICC fields addressing the value side of the deal produce a seller-built business case (Metrics) and a pain assessment (Implicate Pain). Neither field is equivalent to the diagnostic depth in Gap Selling’s current state structure.

The field count shows where each framework places its weight. MEDD(P)ICC is weighted toward the sales cycle. Gap Selling is weighted toward the buyer’s problem environment.

The performance difference between well-qualified and poorly-qualified Gap Selling deals is documented. Data from Noted Analytics shows that deals in the green zone, where at least 75% of fields are covered, carry a 61% win rate, an average deal size of $276,670, and a 74.27-day sales cycle. Deals in the red zone, where field coverage falls below 54%, carry a 7% win rate, an average deal size of $117,500, and a 143.32-day sales cycle. The gap in average deal value between those two tiers is $159,170. The difference in cycle length is 69 days.

Which Fits Your Team

Two diagnostic questions determine what a team needs.

First: when MEDD(P)ICC scorecards look healthy but deals still end without a decision, what failed? If Champion was confirmed, the Economic Buyer was engaged, Decision Criteria were mapped, and both process fields were populated, the qualification looked complete. When those deals still go nowhere, discovery failed. The buyer was never convinced their current situation was untenable enough to act. The seller identified pain without identifying root cause, so the proposal never connected the product to the specific failure it addresses. MEDD(P)ICC had no field that could have caught that failure.

Second: where are losses concentrated? If close rates are low relative to pipeline volume, and if average deal size is smaller than the scope of the problems being sold into should support, that is a diagnostic problem. MEDD(P)ICC’s architecture was not built to improve diagnostic depth. Adding more qualification fields without a methodology behind them produces better-labeled shallow discovery.

Teams starting from scratch need one answer. Gap Selling is a certified methodology with integrated deal management. The diagnostic framework and the deal scoring operate from the same foundational logic, delivered by a single licensed provider, with consistent definitions across implementations. MEDD(P)ICC’s buying cycle fields can function as sub-categories within Gap Selling’s Buying Process field for teams that want to preserve that level of process granularity. There is no conflict in that direction.

When the core problem is that reps cannot run discovery well enough to create the conditions MEDD(P)ICC looks for, the methodology that teaches the diagnosis and the system that tracks it need to be the same thing.

Frequently Asked Questions

Why can’t MEDD(P)ICC tell reps how to run discovery?

MEDD(P)ICC was built to identify whether a deal already has the characteristics of a winner, not to teach reps how to produce those characteristics. A Sales Growth Company describes the limitation directly: “This framework does not contain skills training in terms of what information to gain or how to gain it. It is only a deal management structure intended to connect to a sales methodology.” The Implicate Pain field confirms that a pain conversation occurred but provides no standard for what a complete pain diagnosis looks like. A rep who checks that field may have identified a surface symptom without reaching root cause, without calculating the cost of inaction, or without confirming the buyer’s internal urgency. MEDD(P)ICC records discovery activity without measuring its depth.

What is Root Cause and why does MEDD(P)ICC not have a field for it?

Root Cause in Gap Selling is the specific technical or operational failure inside the buyer’s business producing the business problem. A company experiencing declining close rates might trace that problem to reps who never identify what is broken in the buyer’s current process. When the root cause is identified, the product recommendation can connect to the specific failure rather than the symptom. MEDD(P)ICC bundles problem, impact, technical failure, and emotion under a single pain field derived from the Sandler Pain Funnel. The framework never separates root cause from the broader pain concept, which means reps relying on MEDD(P)ICC alone may construct a proposal around business outcomes without ever connecting the product to the breakdown it resolves. That gap is where differentiation collapses at the final stage.

What is the difference between “pain” and a “business problem” in Gap Selling?

Pain, as used in MEDD(P)ICC and frameworks derived from the Sandler Pain Funnel, refers to the buyer’s combined experience of a problem including emotional consequences, business impacts, and technical symptoms. Gap Selling separates these into four distinct required fields: Business Problem (what the organization is experiencing operationally), Impact (the quantifiable business consequence), Emotion (the personal or organizational feeling attached to the problem), and Root Cause (the technical or operational failure driving the business problem). Treating pain as a unified category makes it harder to build a technically specific proposal. A buyer who has pain around revenue decline could require any number of products. A buyer whose root cause is identified as inadequate discovery execution narrows the solution space considerably and allows the seller to connect the product to the specific failure.

Can MEDD(P)ICC and Gap Selling run at the same time?

Yes. MEDD(P)ICC’s six buying cycle fields, including Champion, Economic Buyer, Competition, Decision Process, Decision Criteria, and Paper Process, can function as sub-categories within Gap Selling’s Buying Process field. Teams currently using MEDD(P)ICC scorecards do not need to abandon them when they adopt Gap Selling. The diagnostic fields in Gap Selling address what MEDD(P)ICC never covers, including Root Cause, Business Problem depth, Emotion as a distinct field, and current and future state completeness. MEDD(P)ICC’s process fields can supplement the Buying Process data with additional granularity. The integration works in one direction: MEDD(P)ICC’s fields fit inside Gap Selling’s architecture. Gap Selling’s current state and future state fields have no equivalent anywhere in MEDD(P)ICC.

What does Gap Selling’s deal scoring measure that MEDD(P)ICC cannot?

Gap Selling’s deal scoring, documented through Noted Analytics, measures field coverage completeness across all 14 fields and correlates that completeness with win rate, average deal size, and sales cycle length. Deals in the green zone (75% or higher field coverage) carry a 61% win rate, a $276,670 average deal size, and a 74.27-day sales cycle. Deals in the red zone (below 54% field coverage) carry a 7% win rate, a $117,500 average deal size, and a 143.32-day sales cycle. MEDD(P)ICC does not have a field coverage standard with documented performance correlation. Its fields can be checked without a defined threshold for completeness, and the framework provides no internal measure of whether a fully scored deal is likely to close.

What is Buyer Input Data and how is it different from MEDD(P)ICC Metrics?

Buyer Input Data (BID) in Gap Selling is the specific quantitative information the buyer provides about the cost of their current business problem and what resolution would be worth to their organization. The buyer’s own numbers establish the cost of inaction relative to the cost of taking action. MEDD(P)ICC Metrics refers to the key performance indicators the seller uses to construct a business case, typically seller-calculated ROI figures illustrating the value of the solution. The distinction is who owns the numbers. A seller-built business case rests on claims the seller makes about value. A buyer-input data set rests on figures the buyer has already confirmed. When the buyer’s own analysis establishes the cost of their current situation, the decision about whether to act sits between the buyer and their own numbers.

If you want the full side-by-side breakdown, download ASG’s Gap Selling meets MEDD(P)ICC guide.

If you are weighing methodologies for your team and want to think it through with someone who has seen this decision play out across hundreds of sales organizations, reach out. No deck, no prepared agenda, just a conversation about the problem you are actually solving. Talk to ASG.